Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals, Inc. | Director | $2.89M | -$2.69M | -48.2% | Dec 2, 2024 |
NKTX | Nkarta, Inc. | Director | Jun 8, 2022 | |||
RLAY | Relay Therapeutics, Inc. | Director | Jun 3, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|